Elevated ghrelin alters the behavioral effects of perinatal acetaminophen exposure in rats. Issue 3 (14th March 2022)

• Record Type: Journal Article
• Authors: Herrington, Joshua A.; Guss Darwich, Janet; Harshaw, Christopher; Brigande, Alev M.; Leif, Erica B.; Currie, Paul J.
• Is Part Of: Developmental psychobiology. Volume 64:Issue 3(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-03-14
• Subjects: acetaminophen -- ghrelin -- neurodevelopment -- neuroprotective -- oxidative stress; Psychobiology -- Periodicals; 155
• DOI: 10.1002/dev.22252
• Languages: English
• ISSNs: 0012-1630

Abstract

Abstract: A growing body of evidence links prenatal and early postnatal acetaminophen (APAP) exposure to atypical development of brain and behavior. In adult rodents, APAP is known to produce oxidative stress and lower anxiety‐related behavior following acute exposure. In models of early‐life exposure, APAP has also been shown to alter anxiety‐related and other behaviors. Since the neuropeptide ghrelin has been recently shown to reduce oxidative stress markers and act as a neuroprotectant, we hypothesized that exposure to ghrelin prior to exposure to APAP would mitigate the behavioral effects of APAP exposure. On postnatal day 7, pups were administered doses of either APAP (51.97 mg/kg), ghrelin (1 mg/kg/ml), ghrelin + APAP, or vehicle only. As adults, anxiety‐related behavior was assessed in the open field and elevated plus maze. Behavior differed based upon treatment condition. In rats unexposed to ghrelin, APAP treatment resulted in increased exploration (i.e., reduced anxiety) in the open field relative to controls. Rats co‐administered APAP and ghrelin did not differ from vehicle‐only controls. No significant effects of APAP or interactions between APAP and ghrelin exposures were observed in the elevated plus maze. These results are the first to demonstrate that ghrelin can mitigate the effects of perinatal APAP exposure in rats.